<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002092'>Pulmonary hypertension</z:hpo> is one of the lethal complications in the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> due to <z:hpo ids='HP_0011010'>chronic</z:hpo> recurrence of embolism or <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We experienced a 19-year-old man suffering from severe <z:hpo ids='HP_0011010'>chronic</z:hpo> thromboembolic <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> (CTEPH) caused by <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>According to the guideline, pulmonary thromboendarterectomy was decided on after combined therapy with <z:chebi fb="8" ids="10033">warfarin</z:chebi>, beraprost and oxygen inhalation had not been effective enough to improve severe CTEPH </plain></SENT>
<SENT sid="3" pm="."><plain>By an operation, the mean pressure of the pulmonary artery was decreased from 50 mmHg to 16 mmHg, while his New York Heart Association (NYHA) functional class classification significantly improved from class III to class I </plain></SENT>
<SENT sid="4" pm="."><plain>We concluded that pulmonary thromboendarterectomy could dramatically improve hemodynamic indices, NYHA functional status and quality of life in patients with CTEPH </plain></SENT>
</text></document>